TrialJournal for immunotherapy of cancer2021

Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study.

Sara Lonardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.